{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T01:57:02Z","timestamp":1783130222761,"version":"3.54.6"},"reference-count":78,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T00:00:00Z","timestamp":1663891200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007199","name":"Utah Agricultural Experiment Station","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007199","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"abstract":"<jats:p>Widely-used <jats:italic>Streptomyces<\/jats:italic>-derived antibacterial aminoglycosides have encountered challenges because of antibiotic resistance and toxicity. Today, they are largely relegated to medicinal topical applications. However, chemical modification to amphiphilic aminoglycosides can revive their efficacy against bacterial pathogens and expand their targets to other pathogenic microbes and disorders associated with hyperactive connexin hemichannels. For example, amphiphilic versions of neomycin and neamine are not subject to resistance and have expanded antibacterial spectra, and amphiphilic kanamycins are effective antifungals and have promising therapeutic uses as connexin hemichannel inhibitors. With further research and discoveries aimed at improved formulations and delivery, amphiphilic aminoglycosides may achieve new horizons in pharmacopeia and agriculture for <jats:italic>Streptomyces<\/jats:italic> aminoglycosides beyond just serving as topical antibacterials.<\/jats:p>","DOI":"10.3389\/fmicb.2022.1000199","type":"journal-article","created":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T05:49:01Z","timestamp":1663912141000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Amphiphilic aminoglycosides: Modifications that revive old natural product antibiotics"],"prefix":"10.3389","volume":"13","author":[{"given":"Jon Y.","family":"Takemoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo A.","family":"Altenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naveena","family":"Poudyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yagya P.","family":"Subedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Wei T.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,9,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"4636","DOI":"10.1128\/AAC.00572-10","article-title":"Synthesis and spectrum of the neoglycoside ACHN-490.","volume":"54","author":"Aggen","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"B2","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1021\/acsmedchemlett.8b00158","article-title":"Inhibition of connexin hemichannels by new amphiphilic amino-glycosides without antibiotic activity.","volume":"9","author":"Alfindee","year":"2018","journal-title":"ACS Med. Chem. Lett"},{"key":"B3","doi-asserted-by":"crossref","DOI":"10.1002\/9780470149676","author":"Arya","year":"2007","journal-title":"Aminoglycoside Antibiotics: From Chemical Biology to Drug Discovery."},{"key":"B4","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s00232-019-00067-4","article-title":"Role of Lipid Composition, Physicochemical Interactions, and Membrane Mechanics in the Molecular Actions of Microbial Cyclic Lipopeptides.","volume":"252","author":"Balleza","year":"2019","journal-title":"J Membr. Biol."},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/9025905","article-title":"Connexin\u2019s Connection in Breast Cancer Growth and Progression.","volume":"2016","author":"Banerjee","year":"2016","journal-title":"Int. J. Cell Biol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"13617","DOI":"10.1002\/anie.201506814","article-title":"Di-N-methylation of anti-gram-positive aminoglycoside-derived membrane disruptors improves antimicrobial potency and broadens spectrum to Gram-negative bacteria.","volume":"54","author":"Benhamou","year":"2015","journal-title":"Angew. Chem. Int. Ed Engl"},{"key":"B7","doi-asserted-by":"publisher","first-page":"6160","DOI":"10.1021\/jm800345u","article-title":"Design, Synthesis, and Antibacterial Activities of Neomycin-Lipid Conjugates: Polycationic Lipids with Potent Gram-Positive Activity.","volume":"51","author":"Bera","year":"2008","journal-title":"J. Med. Chem"},{"key":"B8","doi-asserted-by":"publisher","first-page":"3626","DOI":"10.1021\/jm1000437","article-title":"Antibacterial activities of aminoglycoside antibiotics-derived cationic amphiphiles. Polyol-modified neomycin B-, kanamycin A-, amikacin-, and neamine-based amphiphiles with potent broad spectrum antibacterial activity.","volume":"53","author":"Bera","year":"","journal-title":"J. Med. Chem."},{"key":"B9","doi-asserted-by":"publisher","first-page":"3031","DOI":"10.1016\/j.bmcl.2010.03.116","article-title":"Evaluation of amphiphilic aminoglycoside\u2013peptide triazole conjugates as antibacterial agents.","volume":"20","author":"Bera","year":"","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"B10","doi-asserted-by":"publisher","first-page":"6144","DOI":"10.1021\/ol4030138","article-title":"Site-selective displacement of tobramycin hydroxyls for preparation of antimicrobial cationic amphiphiles.","volume":"15","author":"Berkov-Zrihen","year":"","journal-title":"Org. Lett"},{"key":"B11","doi-asserted-by":"publisher","first-page":"3624","DOI":"10.1016\/j.bmc.2013.03.046","article-title":"Di-alkylated paromomycin derivatives: Targeting the membranes of Gram positive pathogens that cause skin infections.","volume":"21","author":"Berkov-Zrihen","year":"","journal-title":"Bioorg. Med. Chem."},{"key":"B12","author":"Beyer","year":"2009","journal-title":"Connexins: A Guide."},{"key":"B13","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/S0014-5793(02)03755-9","article-title":"Loss-of-function and residual channel activity of connexin26 mutations associated with non-syndromic deafness.","volume":"533","author":"Bruzzone","year":"2003","journal-title":"FEBS Lett."},{"key":"B14","doi-asserted-by":"publisher","first-page":"703","DOI":"10.2165\/00003495-198938050-00003","article-title":"Netilmicin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.","volume":"38","author":"Campoli-Richards","year":"1989","journal-title":"Drugs"},{"key":"B15","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/ja.2010.110","article-title":"Antibacterial to antifungal conversion of neamine aminoglycosides through alkyl modification. Strategy for reviving old drugs into agrofungicides.","volume":"63","author":"Chang","year":"2010","journal-title":"J. Antibiot"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1039\/c4md00078a","article-title":"Antifungal amphiphilic aminoglycosides.","volume":"5","author":"Chang","year":"2014","journal-title":"Med. Chem. Comm."},{"key":"B17","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1097\/HCO.0b013e328352220e","article-title":"Cardiac connexins, mutations and arrhythmias.","volume":"27","author":"Delmar","year":"2012","journal-title":"Curr. Opin. Cardiol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21197411","article-title":"Amphiphilic aminoglycosides as medicinal agents.","volume":"21","author":"Dezanet","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B19","doi-asserted-by":"publisher","first-page":"e00077","DOI":"10.1128\/CMR.00077-17","article-title":"Antibiotic hybrids: The next generation of agents and adjuvants against gram-negative pathogens?","volume":"31","author":"Domalaon","year":"2018","journal-title":"Clin. Microbiol. Rev"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2014.00265","article-title":"Extracellular gentamicin reduces the activity of connexin hemichannels and interferes with purinergic Ca2+ signaling in HeLa cells.","volume":"8","author":"Figueroa","year":"2014","journal-title":"Front. Cell. Neurosci."},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3390\/molecules22122063","article-title":"Inhibition by commercial aminoglycosides of human connexin hemichannels expressed in bacteria.","volume":"22","author":"Fiori","year":"2017","journal-title":"Molecules"},{"key":"B22","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.1093\/emboj\/21.10.2323","article-title":"Substrate promiscuity of an aminoglycoside antibiotic resistance enzyme via target mimicry.","volume":"21","author":"Fong","year":"2002","journal-title":"EMBO J."},{"key":"B23","doi-asserted-by":"publisher","first-page":"4398","DOI":"10.1021\/acs.joc.5b00248","article-title":"Structure\u2013Activity Relationships for Antibacterial to Antifungal Conversion of Kanamycin to Amphiphilic Analogues.","volume":"80","author":"Fosso","year":"2015","journal-title":"J. Org. Chem."},{"key":"B24","doi-asserted-by":"publisher","first-page":"9124","DOI":"10.1021\/acs.jmedchem.5b01375","article-title":"Synthesis and bioactivities of kanamycin b-derived cationic amphiphiles.","volume":"58","author":"Fosso","year":"2015","journal-title":"J. Med. Chem."},{"key":"B25","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1039\/c5md00344j","article-title":"Mechanisms of resistance to aminoglycoside antibiotics: Overview and perspectives.","volume":"7","author":"Garneau-Tsodikova","year":"2016","journal-title":"Med. Chem. Commun."},{"key":"B26","first-page":"1811","article-title":"Aminoglycosides: A practical review.","volume":"58","author":"Gonzalez","year":"1998","journal-title":"Am. Fam. Physician"},{"key":"B27","doi-asserted-by":"publisher","first-page":"5652","DOI":"10.1002\/anie.201200761","article-title":"6\u2033-Thioether tobramycin analogues: Towards selective targeting of bacterial membranes.","volume":"51","author":"Herzog","year":"2012","journal-title":"Angew. Chem. Int. Ed"},{"key":"B28","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1039\/d0fd00041h","article-title":"Antimicrobial peptides: Mechanism of action and lipid-mediated synergistic interactions within membranes.","volume":"232","author":"Juhi","year":"2021","journal-title":"Faraday Discuss"},{"key":"B29","doi-asserted-by":"publisher","first-page":"695","DOI":"10.7164\/antibiotics.25.695","article-title":"BB-K8, a new semisynthetic aminoglycoside antibiotic.","volume":"25","author":"Kawaguchi","year":"1972","journal-title":"J. Antibiot"},{"key":"B30","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/0924-8579(95)00014-Y","article-title":"Arbekacin.","volume":"5","author":"Kobayashi","year":"1995","journal-title":"Intl. J. Antimicrobial. Agents"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/10934529.2020.1830653","article-title":"Cytotoxic effect of aminoglycoside antibiotics on the mammalian cell lines.","volume":"56","author":"Kovacik","year":"2021","journal-title":"J. Environ. Sci. Health Part A"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a027029","article-title":"Aminoglycosides: An overview.","volume":"6","author":"Krause","year":"2016","journal-title":"Cold Spring Harb. Perspect. Med"},{"key":"B33","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1111\/j.1365-2672.2005.02684.x","article-title":"Activity of some aminoglycoside antibiotics against true fungi, Phytophthora and Pythium species.","volume":"99","author":"Lee","year":"2005","journal-title":"J. Appl. Microbiol."},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1017\/S1462399409001276","article-title":"Connexin-26 mutations in deafness and skin disease.","volume":"11","author":"Lee","year":"2009","journal-title":"Expert Rev. Mol. Med"},{"key":"B35","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1124\/pr.115.012062","article-title":"Connexins in cardiovascular and neurovascular health and disease: Pharmacological implications.","volume":"69","author":"Leybaert","year":"2017","journal-title":"Pharmacol. Rev."},{"key":"B36","doi-asserted-by":"publisher","first-page":"3212","DOI":"10.1021\/acsinfecdis.0c00588","article-title":"Serum prevents interactions between antimicrobial amphiphilic aminoglycosides and plasma membranes.","volume":"6","author":"Logviniuk","year":"2020","journal-title":"ACS Infect. Dis."},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-019-1036-y","article-title":"Inhibition of connexin 43 attenuates oxidative stress and apoptosis in human umbilical vein endothelial cells.","volume":"20","author":"Ma","year":"2020","journal-title":"BMC Pulm. Med."},{"key":"B38","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/s00439-006-0245-7","article-title":"Novel aminoglycosides increase SMN levels in spinal muscular atrophy fibroblasts.","volume":"120","author":"Mattis","year":"2006","journal-title":"Hum. Genet."},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2202-10-142","article-title":"Subcutaneous administration of TC007 reduces disease severity in an animal model of SMA.","volume":"10","author":"Mattis","year":"2009","journal-title":"BMC Neurosci"},{"key":"B40","doi-asserted-by":"publisher","first-page":"2516","DOI":"10.1038\/sj.jid.5700770","article-title":"Gap junctions: Basic structure and function.","volume":"127","author":"Me\u015fe","year":"2007","journal-title":"J. Invest. Dermatol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.jconrel.2011.12.019","article-title":"Paromomycin and neomycin B derived cationic lipids: Synthesis. and transfection studies.","volume":"158","author":"M\u00e9vel","year":"2012","journal-title":"J. Control. Release"},{"key":"B42","doi-asserted-by":"publisher","first-page":"688","DOI":"10.7164\/antibiotics.31.688","article-title":"Biological activity of sch 21420, the 1-n-s-\u03b1-hydroxy-\u03b2-aminopropionyl derivative of gentamicin B.","volume":"31","author":"Miller","year":"1978","journal-title":"J. Antibiot."},{"key":"B43","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1039\/C5MD00503E","article-title":"Bacterial lipid membranes as promising targets to fight antimicrobial resistance, molecular foundations and illustration through the renewal of aminoglycoside antibiotics and emergence of amphiphilic aminoglycosides.","volume":"7","author":"Mingeot-Leclercq","year":"2016","journal-title":"Med. Chem. Commun"},{"key":"B44","doi-asserted-by":"publisher","first-page":"681","DOI":"10.7164\/antibiotics.31.681","article-title":"The syntheses and biological properties of l-n-(s-4-amino- 2-hydroxybutyryl)-gentamicin b and 1-n-(s-3-amino- 2-hydroxypropionyl)-gentamicin B.","volume":"31","author":"Nagabhushan","year":"1978","journal-title":"J. Antibiot"},{"key":"B45","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/nrc.2016.105","article-title":"Gap junctions and cancer: Communicating for 50 years.","volume":"10","author":"Naus","year":"2010","journal-title":"Nat. Rev. Cancer"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1002\/cphy.c110051","article-title":"Gap junctions.","volume":"2","author":"Nielsen","year":"2012","journal-title":"Compr. Physiol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1159\/000493230","article-title":"Connexin 43: A new therapeutic target against chronic kidney disease.","volume":"49","author":"Prakoura","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"key":"B48","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.drup.2010.08.003","article-title":"Aminoglycoside modifying enzymes.","volume":"13","author":"Ramirez","year":"2010","journal-title":"Drug Resist. Updat."},{"key":"B49","doi-asserted-by":"publisher","first-page":"2764","DOI":"10.1002\/ejoc.200300164","article-title":"Aminoglycoside-derived cationic lipids for gene transfection: Synthesis of kanamycin A derivatives.","volume":"15","author":"Sainlos","year":"2003","journal-title":"Eur. J. Org. Chem."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1021\/jm00108a035","article-title":"New derivatives of kanamycin B obtained by modifications and substitutions in position 6\u2033. 1. Synthesis and microbiological evaluation.","volume":"34","author":"Schepdael","year":"1991","journal-title":"J. Med. Chem."},{"key":"B51","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.pharmthera.2015.06.005","article-title":"Connexin 43 is an emerging therapeutic target in ischemia\/reperfusion injury, cardioprotection and neuroprotection.","volume":"153","author":"Schulz","year":"2015","journal-title":"Pharmacol. Ther."},{"key":"B52","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s00232-019-00068-3","article-title":"Interaction of Antimicrobial Lipopeptides with Bacterial Lipid Bilayers.","volume":"252","author":"Shahane","year":"2019","journal-title":"J. Membr. Biol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"H1714","DOI":"10.1152\/AJPHEART.00022.2007","article-title":"Hemichannels in cardiomyocytes open transiently during ischemia and contribute to reperfusion injury following brief ischemia.","volume":"293","author":"Shintani-Ishida","year":"2007","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2014.00671","article-title":"Antifungal amphiphilic aminoglycoside K20: Bioactivities and mechanism of action.","volume":"5","author":"Shrestha","year":"2014","journal-title":"Front. Microbiol."},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0073843","article-title":"Membrane lipid-modulated mechanism of action and non-cytotoxicity of novel fungicide aminoglycoside FG08.","volume":"8","author":"Shrestha","year":"2013","journal-title":"PLoS One"},{"key":"B56","doi-asserted-by":"publisher","first-page":"4861","DOI":"10.1128\/AAC.00229-15","article-title":"Amphiphilic tobramycin analogues as antibacterial and antifungal agents.","volume":"59","author":"Shrestha","year":"","journal-title":"Antimicrob. Agents Chemother."},{"key":"B57","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1093\/mmy\/myv063","article-title":"In vitro antifungal synergy between amphiphilic aminoglycoside K20 and azoles against Candida species and Cryptococcus neoformans.","volume":"53","author":"Shrestha","year":"","journal-title":"Med. Mycol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"E5934","DOI":"10.1073\/pnas.1803907115","article-title":"Suppression of connexin 43 phosphorylation promotes astrocyte survival and vascular regeneration in proliferative retinopathy.","volume":"115","author":"Slavi","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"B59","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1021\/acsinfecdis.7b00272","article-title":"Increased degree of unsaturation in the lipid of antifungal cationic amphiphiles facilitates selective fungal cell disruption.","volume":"4","author":"Steinbuch","year":"2018","journal-title":"ACS Infect. Dis."},{"key":"B60","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1039\/c8md00155c","article-title":"Antifungal amphiphilic kanamycins: New life for an old drug.","volume":"9","author":"Subedi","year":"2018","journal-title":"Med. Chem. Comm."},{"key":"B61","doi-asserted-by":"publisher","first-page":"379","DOI":"10.4155\/fmc-2020-0291","article-title":"Advances in the development of connexin hemichannel inhibitors selective toward Cx43.","volume":"13","author":"Subedi","year":"2021","journal-title":"Futur. Med. Chem."},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2020.112602","article-title":"Amphiphilic aminoglycosides with increased selectivity for inhibition of connexin 43 (Cx43) hemichannels.","volume":"203","author":"Subedi","year":"","journal-title":"Eur. J. Med. Chem"},{"key":"B63","author":"Subedi","year":"","journal-title":"Scalable and cost-effective synthesis of antifungal amphiphilic kanamycin"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2019.111639","article-title":"Scalable and cost-effective tosylation-mediated synthesis of antifungal and fungal diagnostic 6\u2033-Modified amphiphilic kanamycins.","volume":"182","author":"Subedi","year":"","journal-title":"Eur. J. Med. Chem"},{"key":"B65","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1021\/acsinfecdis.8b00327","article-title":"Development of fungal selective amphiphilic kanamycin: Cost effective synthesis and use of fluorescent analogs for mode of action investigation.","volume":"5","author":"Subedi","year":"","journal-title":"ACS Infect. Dis."},{"key":"B66","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1002\/cmdc.201100346","article-title":"Inhibition of aminoglycoside-deactivating enzymes aph(3\u2032)-iiia and aac(6\u2032)-ii by amphiphilic paromomycin o2\u2033-ether analogues.","volume":"6","author":"Szychowski","year":"2011","journal-title":"ChemMedChem"},{"key":"B67","author":"Takemoto","year":"2010","journal-title":"Investigation of antifungal activity of amphiphilic neomycin"},{"key":"B68","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.funbio.2017.12.001","article-title":"Suppression of Wheat Fusarium Head Blight by Novel Amphiphilic Aminoglycoside Fungicide K20.","volume":"122","author":"Takemoto","year":"2018","journal-title":"Fungal Biol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1016\/j.bmcl.2013.01.073","article-title":"Investigation of antibacterial mode of action for traditional and amphiphilic aminoglycosides.","volume":"23","author":"Udumula","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"B70","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-642-68579-8","author":"Umezawa","year":"1982","journal-title":"Aminoglycoside Antibiotics."},{"key":"B71","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1021\/jm00340a034","article-title":"Gentamicin, a new antibiotic complex from micromonospora.","volume":"6","author":"Weinstein","year":"1963","journal-title":"J. Med. Chem"},{"key":"B72","doi-asserted-by":"publisher","first-page":"551","DOI":"10.7164\/antibiotics.23.551","article-title":"Antibiotic 6640, a new micromonospora-produced aminoglycoside antibiotic.","volume":"23","author":"Weinstein","year":"1970","journal-title":"J. Antibiot"},{"key":"B73","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.heares.2011.05.008","article-title":"New developments in aminoglycoside therapy and ototoxicity.","volume":"281","author":"Xie","year":"2011","journal-title":"Hear. Res."},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/9312827","article-title":"The Role of Connexin-43 in the Inflammatory Process: A New Potential Therapy to Influence Keratitis.","volume":"2019","author":"Xu","year":"2019","journal-title":"J. Ophthalmol."},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-019-02190-1","article-title":"The important role of connexin 43 in subarachnoid hemorrhage-induced cerebral vasospasm.","volume":"17","author":"Yang","year":"2019","journal-title":"J. Transl. Med."},{"key":"B76","doi-asserted-by":"publisher","first-page":"7563","DOI":"10.1021\/jm800997s","article-title":"Surprising alteration of antibacterial activity of 5\u2033-modified neomycin against resistant bacteria.","volume":"51","author":"Zhang","year":"2008","journal-title":"J. Med. Chem"},{"key":"B77","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/ja.2009.66","article-title":"Synthesis and Combinational Antibacterial Study of 5\u2033-Modified Neomycin.","volume":"62","author":"Zhang","year":"2009","journal-title":"J. Antibiot"},{"key":"B78","doi-asserted-by":"publisher","first-page":"9350","DOI":"10.1021\/acs.jmedchem.6b00818","article-title":"New Broad-Spectrum Antibacterial Amphiphilic Aminoglycosides Active against Resistant Bacteria: From Neamine Derivatives to Smaller Neosamine Analogues.","volume":"59","author":"Zimmermann","year":"2016","journal-title":"J. Med. Chem."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2022.1000199\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T05:49:14Z","timestamp":1663912154000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2022.1000199\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,23]]},"references-count":78,"alternative-id":["10.3389\/fmicb.2022.1000199"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2022.1000199","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,23]]},"article-number":"1000199"}}